Clinical trials
Anemia trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 7 |
| Active, not recruiting | 5 |
| Unknown status | 5 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Amgen | 4 |
| Hoffmann-La Roche | 4 |
| Agios Pharmaceuticals, Inc. | 3 |
| Radboud University Medical Center | 3 |
| Abbott Medical Devices | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| CTI BioPharma | 2 |
| Celgene | 2 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 44 |
| Hematologic Diseases | 7 |
| Myelodysplastic Syndromes | 6 |
| Neoplasms | 4 |
| Renal Insufficiency, Chronic | 4 |
| Thrombocytopenia | 4 |
| Hemoglobinuria, Paroxysmal | 3 |
| Primary Myelofibrosis | 3 |
| Anemia, Diamond-Blackfan | 2 |
| Anemia, Hemolytic | 2 |
Trials
Showing 51 to 44 of 44. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.